Incyte Biosciences Denmark ApS — Credit Rating and Financial Key Figures
CVR number: 35818790
Suomisvej 4, 1927 Frederiksberg C
co.sec@incyte.com
tel: 20663890
Income statement (kDKK)
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 | 12 |
| Net sales | |||||
| Gross profit | 4 829.93 | 5 397.38 | 5 287.82 | 5 556.64 | 6 283.40 |
| Employee benefit expenses | -4 449.00 | -5 183.27 | -4 924.20 | -5 185.16 | -5 798.73 |
| EBIT | 380.92 | 214.11 | 363.63 | 371.48 | 484.67 |
| Other financial income | 0.07 | ||||
| Other financial expenses | -14.77 | -14.66 | -18.05 | -16.86 | 1.28 |
| Pre-tax profit | 366.23 | 199.44 | 345.58 | 354.63 | 485.95 |
| Income taxes | -80.56 | -49.02 | -77.04 | -76.68 | - 111.36 |
| Net earnings | 285.66 | 150.43 | 268.53 | 277.95 | 374.58 |
Assets (kDKK)
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Intangible assets total | |||||
| Tangible assets total | |||||
| Other receivables | 23.18 | 23.18 | 23.18 | 37.25 | 38.73 |
| Investments total | 23.18 | 23.18 | 23.18 | 37.25 | 38.73 |
| Long term receivables total | |||||
| Inventories total | |||||
| Current amounts owed by group member comp. | 1 623.84 | 2 893.29 | 2 046.45 | 5 462.06 | 949.57 |
| Prepayments and accrued income | 44.44 | 62.73 | 128.82 | ||
| Current other receivables | 36.04 | 319.06 | 306.92 | 826.42 | 2 028.17 |
| Current deferred tax assets | 12.00 | 4.36 | |||
| Short term receivables total | 1 704.32 | 3 275.08 | 2 482.19 | 6 300.48 | 2 982.10 |
| Cash and bank deposits | 696.92 | 72.80 | 936.82 | 653.42 | 1 582.64 |
| Cash and cash equivalents | 696.92 | 72.80 | 936.82 | 653.42 | 1 582.64 |
| Balance sheet total (assets) | 2 424.42 | 3 371.05 | 3 442.19 | 6 991.15 | 4 603.46 |
Equity and liabilities (kDKK)
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Share capital | 50.00 | 50.00 | 50.00 | 50.00 | 50.00 |
| Retained earnings | 191.32 | 476.98 | 627.41 | 895.94 | 1 173.89 |
| Profit of the financial year | 285.66 | 150.43 | 268.53 | 277.95 | 374.58 |
| Shareholders equity total | 526.98 | 677.41 | 945.94 | 1 223.89 | 1 598.47 |
| Non-current liabilities total | |||||
| Current trade creditors | 7.29 | 36.03 | 352.78 | 170.88 | 12.19 |
| Current owed to group member | 500.00 | 500.00 | 500.00 | 4 436.29 | 242.36 |
| Short-term deferred tax liabilities | 74.57 | 43.02 | 59.04 | ||
| Other non-interest bearing current liabilities | 1 315.57 | 2 114.60 | 1 584.43 | 1 160.09 | 2 750.44 |
| Current liabilities total | 1 897.43 | 2 693.64 | 2 496.25 | 5 767.27 | 3 004.99 |
| Balance sheet total (liabilities) | 2 424.42 | 3 371.05 | 3 442.19 | 6 991.15 | 4 603.46 |
Try the full version of our system for free
Create your own estimates for any company
Valuation analysis
See instructions
... and more!
No registration needed.